Rodríguez-Rodríguez L - Search Results

1

Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire.

Sancho-Torres I, Mesonero C, Miller Watelet JL, Gibbon D, Rodríguez-Rodríguez L. Sancho-Torres I, et al. Gynecol Oncol. 2000 Nov;79(2):187-95. doi: 10.1006/gyno.2000.5938. Gynecol Oncol. 2000. PMID: 11063642 Free article.

2

CD44 splice variant expression in clear cell carcinoma of the ovary.

Rodríguez-Rodríguez L, Sancho-Torres I, Leakey P, Gibbon DG, Comerci JT, Ludlow JW, Mesonero C. Rodríguez-Rodríguez L, et al. Gynecol Oncol. 1998 Nov;71(2):223-9. doi: 10.1006/gyno.1998.5108. Gynecol Oncol. 1998. PMID: 9826464 Free article.

3

Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva.

Rodríguez-Rodríguez L, Sancho-Torres I, Miller Watelet L, Gibbon DG, Comerci JT, Mesonero C. Rodríguez-Rodríguez L, et al. Gynecol Oncol. 1999 Oct;75(1):34-40. doi: 10.1006/gyno.1999.5560. Gynecol Oncol. 1999. PMID: 10502422

4

CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva.

Rodríguez-Rodríguez L, Sancho-Torres I, Gibbon DG, Watelet LF, Mesonero C. Rodríguez-Rodríguez L, et al. J Soc Gynecol Investig. 2000 Jan-Feb;7(1):70-5. doi: 10.1016/s1071-5576(99)00045-3. J Soc Gynecol Investig. 2000. PMID: 10732319

5

The CD44 receptor is a molecular predictor of survival in ovarian cancer.

Rodríguez-Rodríguez L, Sancho-Torres I, Mesonero C, Gibbon DG, Shih WJ, Zotalis G. Rodríguez-Rodríguez L, et al. Med Oncol. 2003;20(3):255-63. doi: 10.1385/MO:20:3:255. Med Oncol. 2003. PMID: 14514975

6

Phase I trial of selenium plus chemotherapy in gynecologic cancers.

Song M, Kumaran MN, Gounder M, Gibbon DG, Nieves-Neira W, Vaidya A, Hellmann M, Kane MP, Buckley B, Shih W, Caffrey PB, Frenkel GD, Rodriguez-Rodriguez L. Song M, et al. Gynecol Oncol. 2018 Sep;150(3):478-486. doi: 10.1016/j.ygyno.2018.07.001. Epub 2018 Jul 29. Gynecol Oncol. 2018. PMID: 30068487 Free PMC article. Clinical Trial.

7

Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer.

Song M, DiPaola RS, Cracchiolo BM, Gibbon DG, Hellmann M, Nieves-Neira W, Vaidya A, Wagreich AR, Shih WJ, Rodriguez-Rodriguez L. Song M, et al. Int J Gynecol Cancer. 2014 Nov;24(9):1636-41. doi: 10.1097/IGC.0000000000000258. Int J Gynecol Cancer. 2014. PMID: 25304678 Free PMC article. Clinical Trial.

8

Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

Rodriguez-Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S. Rodriguez-Rodriguez L, et al. Gynecol Oncol. 2016 Apr;141(1):2-9. doi: 10.1016/j.ygyno.2016.02.021. Gynecol Oncol. 2016. PMID: 27016222 Free PMC article. Clinical Trial.

9

Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature.

O'Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez-Rodriguez L. O'Hanlan KA, et al. Gynecol Oncol. 1991 Nov;43(2):167-72. doi: 10.1016/0090-8258(91)90066-e. Gynecol Oncol. 1991. PMID: 1660433 Review.

10

Virulence of papillary endometrial carcinoma.

O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, Rodriguez-Rodriguez L. O'Hanlan KA, et al. Gynecol Oncol. 1990 Apr;37(1):112-9. doi: 10.1016/0090-8258(90)90318-f. Gynecol Oncol. 1990. PMID: 2323606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters